I Iacona

1.2k total citations
27 papers, 970 citations indexed

About

I Iacona is a scholar working on Surgery, Molecular Biology and Hematology. According to data from OpenAlex, I Iacona has authored 27 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in I Iacona's work include Retinoids in leukemia and cellular processes (7 papers), Acute Myeloid Leukemia Research (6 papers) and Clinical Nutrition and Gastroenterology (6 papers). I Iacona is often cited by papers focused on Retinoids in leukemia and cellular processes (7 papers), Acute Myeloid Leukemia Research (6 papers) and Clinical Nutrition and Gastroenterology (6 papers). I Iacona collaborates with scholars based in Italy, Switzerland and Canada. I Iacona's co-authors include Mario Regazzi, Francesco Zaja, Carlo Campana, Mario Lazzarino, Antonello Gavazzi, G Perani, Luca Arcaini, M Viganò, Enrica Morra and Michele Baccarani and has published in prestigious journals such as Cancer, Nutrients and British Journal of Haematology.

In The Last Decade

I Iacona

27 papers receiving 935 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Iacona Italy 17 238 194 173 171 161 27 970
G. De Sandre Italy 19 101 0.4× 163 0.8× 257 1.5× 78 0.5× 87 0.5× 74 1.4k
François Glowacki France 24 112 0.5× 149 0.8× 582 3.4× 96 0.6× 148 0.9× 83 1.8k
Jay Garg United States 15 232 1.0× 144 0.7× 147 0.8× 218 1.3× 278 1.7× 42 2.6k
Jennifer F. Yamamoto United States 16 109 0.5× 149 0.8× 304 1.8× 62 0.4× 225 1.4× 17 2.0k
D Cordonnier France 19 80 0.3× 112 0.6× 193 1.1× 79 0.5× 30 0.2× 69 1.6k
Philippe Zaoui France 20 96 0.4× 195 1.0× 401 2.3× 77 0.5× 158 1.0× 66 1.6k
Robert Matthew Strother United States 18 81 0.3× 94 0.5× 283 1.6× 60 0.4× 298 1.9× 46 891
D P Bentley United Kingdom 18 46 0.2× 394 2.0× 316 1.8× 288 1.7× 144 0.9× 35 1.3k
Carin E. Dugowson United States 17 161 0.7× 81 0.4× 83 0.5× 49 0.3× 61 0.4× 26 991
Lidija Orlić Croatia 20 167 0.7× 102 0.5× 116 0.7× 67 0.4× 74 0.5× 70 1.5k

Countries citing papers authored by I Iacona

Since Specialization
Citations

This map shows the geographic impact of I Iacona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Iacona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Iacona more than expected).

Fields of papers citing papers by I Iacona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Iacona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Iacona. The network helps show where I Iacona may publish in the future.

Co-authorship network of co-authors of I Iacona

This figure shows the co-authorship network connecting the top 25 collaborators of I Iacona. A scholar is included among the top collaborators of I Iacona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Iacona. I Iacona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caccialanza, Riccardo, Alessandro Laviano, Federica Lobascio, et al.. (2020). Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol. Nutrition. 74. 110835–110835. 177 indexed citations
2.
Caccialanza, Riccardo, Emanuele Cereda, Catherine Klersy, et al.. (2015). Phase Angle and Handgrip Strength Are Sensitive Early Markers of Energy Intake in Hypophagic, Non-Surgical Patients at Nutritional Risk, with Contraindications to Enteral Nutrition. Nutrients. 7(3). 1828–1840. 30 indexed citations
3.
Lazzarino, Mario, Luca Arcaini, Ester Orlandi, et al.. (2005). Immunochemotherapy with Rituximab, Vincristine and 5-Day Cyclophosphamide for Heavily Pretreated Follicular Lymphoma. Oncology. 68(2-3). 146–153. 7 indexed citations
4.
Regazzi, Mario, I Iacona, Maria Antonietta Avanzini, et al.. (2005). Pharmacokinetic Behavior of Rituximab. Therapeutic Drug Monitoring. 27(6). 785–792. 74 indexed citations
5.
Arcaini, Luca, Ester Orlandi, E. P. Alessandrino, et al.. (2004). A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma. Bone Marrow Transplantation. 34(2). 175–179. 16 indexed citations
6.
Zaja, Francesco, I Iacona, Paola Masolini, et al.. (2002). B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.. PubMed. 87(2). 189–95. 111 indexed citations
8.
Regazzi, Mario, et al.. (2001). Pharmacokinetics of tacrolimus during the early phase after heart transplantation. Transplantation Proceedings. 33(3). 2386–2389. 11 indexed citations
9.
Alessiani, M, Mario Regazzi, Paola Ferrari, et al.. (2000). Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus. Transplantation Proceedings. 32(6). 1214–1215. 2 indexed citations
10.
Carli, Modesto, et al.. (2000). All-trans retinoic acid and interferon-α in the treatment of a patient with resistant metastatic osteosarcoma. Cancer. 89(12). 2661–2666. 21 indexed citations
11.
Iacona, I, Mario Lazzarino, Maria Antonietta Avanzini, et al.. (2000). Rituximab (IDEC-C2B8): Validation of a Sensitive Enzyme-Linked Immunoassay Applied to a Clinical Pharmacokinetic Study. Therapeutic Drug Monitoring. 22(3). 295–301. 58 indexed citations
12.
Russo, Domenico, I Iacona, Stefano Sacchi, et al.. (1998). Time-Dependent Kinetics of Tretinoin in Chronic Myelogenous Leukaemia during Intermittent Dose Scheduling. Clinical Drug Investigation. 16(1). 25–33. 2 indexed citations
13.
Russo, Domenico, Mario Regazzi, Stefano Sacchi, et al.. (1998). All-trans retinoic acid (ATRA) in patients with chronic myeloid leukemia in the chronic phase. Leukemia. 12(4). 449–454. 16 indexed citations
14.
Spada, Marco, M Alessiani, Paolo Ferrari, et al.. (1997). Tacrolimus and mycophenolate mofetil in pig small bowel transplantation: Different protocols and their outcome. Transplantation Proceedings. 29(3). 1819–1820. 2 indexed citations
15.
Iacona, I, M Alessiani, Marco Spada, & Mario Regazzi. (1997). Mycophenolic acid in combination with FK 506: A pharmacokinetic study in piglets after small-bowel transplantation. Transplantation Proceedings. 29(1-2). 701–702. 2 indexed citations
16.
Regazzi, Mario, M Alessiani, P. Reggiani, et al.. (1997). Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. Transplantation Proceedings. 29(3). 1857–1860. 13 indexed citations
17.
Regazzi, Mario, et al.. (1997). Clinical Pharmacokinetics of Tretinoin. Clinical Pharmacokinetics. 32(5). 382–402. 50 indexed citations
18.
Lazzarino, Mario, Alessandro Corso, Mario Regazzi, I Iacona, & Carlo Bernasconi. (1995). Modulation of all‐trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon‐α therapy. British Journal of Haematology. 90(4). 928–930. 14 indexed citations
19.
Iacona, I, et al.. (1994). High-Performance Liquid Chromatography Determination of Pravastatin in Plasma. Therapeutic Drug Monitoring. 16(2). 191–195. 23 indexed citations
20.
Regazzi, Mario, I Iacona, Carlo Campana, et al.. (1994). Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.. PubMed. 26(5). 2644–5. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026